Oasmia Pharmaceutical AB Comprehensive Income
Oasmia Pharmaceutical AB reported Comprehensive Income of -SEK 118.04 million for the 12-month period ending 2018-04-30, per its 20-F filed 2018-09-14.
Discontinued › Income Statement › Unrealized Gains
ifrs-full:ComprehensiveIncome · last filed 2018-09-14
| Period end | Comprehensive Income 12 month |
|---|---|
| 2018-04-30 | -118.04M SEK 20-F · filed 2018-09-14 |
| 2017-04-30 | -160.23M SEK 20-F · filed 2018-09-14 |
| 2016-04-30 | -141.56M SEK 20-F · filed 2018-09-14 |